Shell Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
DG
Shell Asset Management's HCAT Position: Q1 2024 in Review
Shell Asset Management sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 14,807 shares — an estimated $137K sold.
Shell Asset Management first reported a position in HCAT in Q3 2023 and held it in 2 quarters. The position peaked at $195K in Q3 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.
- Shell Asset Management reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
- Shell Asset Management sold 14,807 Health Catalyst shares in Q1 2024, an estimated $137K.
- Shell Asset Management first reported a position in Health Catalyst in Q3 2023 and held it in 2 quarters.
- Shell Asset Management's Health Catalyst position peaked at $195K in Q3 2023.
- 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.
Based on Shell Asset Management's 13F filing for Q1 2024, filed 14 May 2024.